Unique ID issued by UMIN | UMIN000055015 |
---|---|
Receipt number | R000062851 |
Scientific Title | Development and validation of Japanese version of Alzheimer's disease Cooperative Study scale for ADL in MCI (ADCS-MCI-ADL) |
Date of disclosure of the study information | 2024/07/18 |
Last modified on | 2024/07/18 19:38:22 |
Development and validation of Japanese version of Alzheimer's disease Cooperative Study scale for ADL in MCI (ADCS-MCI-ADL)
Development of Japanese version of ADCS-MCI-ADL
Development and validation of Japanese version of Alzheimer's disease Cooperative Study scale for ADL in MCI (ADCS-MCI-ADL)
Development and validation of Japanese version of ADCS-MCI-ADL
Japan |
Alzheimer's disease
Psychiatry |
Others
NO
This study aims to develop and validate the Japanese version of ADCS-MCI-ADL (ADCS-MCI-ADL-J).
Others
To develop and validate the ADCS-MCI-ADL-J
Reliability, validity, and interpretability of ADCS-MCI-ADL-J
Observational
40 | years-old | <= |
Not applicable |
Male and Female
<Inclusion criteria>
- Diagnosis of MCI due to AD or ADD according to the National Institute on Aging-Alzheimer's Association 2011 criteria
- Clinical Dementia Rating (CDR) global score < 2
- Over 40 years old
- Existence of caregivers who are familiar with participant's daily livings
- Written informed consent was obtained from patients and/or caregivers.
<Inclusion criteria for healthy control>
- Over 40 years old
- Absence of subjective cognitive decline
- Absence of obvious cognitive impairment
- Absence of obvious disability in ADL
- Written informed consent was obtained from participants
<Exclusion criteria>
- Drug induced, or vascular dementia
- Existence of severe medical disease
- Comorbidity of other psychiatric disease such as schizophrenia, mood disorders, or drug abuse
- Judgment made by the research director/co-researcher that study participation would negatively influence the patient's condition
<Exclusion criteria for healthy control>
- Existence of psychiatric or neurological disease that impair the cognitive function
120
1st name | Manabu |
Middle name | |
Last name | Ikeda |
Osaka University
Department of Psychiatry, Course of Integrated Medicine, Graduate School of Medicine
565-0871
2-2 D3, Yamadaoka, Suita-city, Osaka
06-6879-3051
mikeda@psy.med.osaka-u.ac.jp
1st name | Daiki |
Middle name | |
Last name | Ishimaru |
Osaka University Hospital
Department of Medical Technology
565-0871
2-15, Yamadaoka, Suita-city, Osaka
06-6879-3051
d.ishimaru@psy.med.osaka-u.ac.jp
Osaka University
Ministry of Health, Labour and Welfare
Japanese Governmental office
Ethical Review Board Osaka University Hospital
2-2, Yamadaoka, Suita-city, Osaka
06-6210-8296
rinri@hp-crc.med.osaka-u.ac.jp
NO
2024 | Year | 07 | Month | 18 | Day |
Unpublished
Enrolling by invitation
2023 | Year | 10 | Month | 13 | Day |
2023 | Year | 10 | Month | 13 | Day |
2024 | Year | 03 | Month | 11 | Day |
2026 | Year | 03 | Month | 31 | Day |
Participants are inpatients or outpatients at study institutions between 13 October 2023 and 31 March 2026, who meet the inclusion criteria and do not meet the exclusion criteria.
2024 | Year | 07 | Month | 18 | Day |
2024 | Year | 07 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000062851
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |